Japan has conditionally approved two regenerative therapies based on induced pluripotent stem cells (iPS). This marks the world’s first commercial use of this technology in treating Parkinson’s disease and severe heart failure.
During a federal court hearing in Boston, a lawyer for the US Department of Justice argued that Health Secretary Robert F. Kennedy Jr. has such broad authority over vaccination policy that his decisions – even potentially controversial ones – may be largely beyond judicial review. The case concerns a lawsuit filed by medical organizations challenging recent changes to federal vaccination recommendations.
Aging had long appeared to be a slow wear and tear of everything at once. As we previously mentioned, it is increasingly described today as a set of specific malfunctions that can be measured and partly corrected in animal experiments. This article looks at what can already be done about aging associated with such hallmarks as protein quality control, mitochondrial function (the cell’s power plants), and the accumulation of senescent cells – those that have stopped dividing and functioning for the benefit of the organism yet continue to damage the surrounding environment. These processes reinforce one another.
Have you ever heard a doctor say something like: “Didn’t this help you at all? Hmm. Ok, let’s try these pills instead”? How does it feel to be a lab rat? Of course it’s not human experimentation — but what if you could get the right therapy without all that trial and error? Imagine your doctor had an exact copy of you to test all their ideas on — not on you. Wouldn’t that be fantastic? Today, this isn’t entirely science fiction. You can give your doctor a digital twin to experiment on.
Robot-assisted surgery is still perceived as “the future is here,” a hallmark of high-tech medicine, and is on the verge of becoming routine practice. In eye microsurgery, where microscopic precision of movements is critical, robotic surgical assistants are often indispensable. But now Chinese medical researchers have developed and begun testing a robot capable of performing intraocular surgeries autonomously. Soon, we may face a situation where the human surgeon doesn’t control the robot-surgeon at all, but simply observes. Who will bear responsibility for the surgical outcome? Isn’t the risk too high?
Most age-related diseases — from cancer to neurodegeneration — connect back to one core problem: over time, cells get worse at storing their DNA safely and using it correctly. In the “Hallmarks of Aging” framework(which we discussed here), researchers highlight three aging processes that sit right on top of our genetic material: DNA damage, telomere shortening, and epigenetic drift, when the settings that control gene activity get noisy.
Artificial intelligence is beginning to outperform humans in narrow but economically consequential tasks, raising anxieties about job security and even agency. We are seriously discussing the possibility of losing control over AI. And one of the proposed ways of dealing with it is integration: linking the nervous system to digital tools through the brain-computer interfaces (BCIs).
In recent years, GLP-1–based weight-loss drugs have decisively moved beyond a narrow medical topic and become a mainstream subject of discussion in the US, Europe, and Canada. Explosive demand growth, intensifying competition, and expectations of change driven by patent timelines have turned the search for Ozempic alternatives into a practical question: what should you choose if Ozempic is hard to obtain, too expensive, or poorly tolerated?
The word “rejuvenation” covers everything from cosmetics and supplements to lab work that tries to change how cells age — and, in turn, how age-related disease risk builds up. This article is a short guide to the science-backed version of that conversation: what geroscience is, what the Hallmarks of Aging are, and why investors are pouring billions into the space.
European Association of Preventive Cardiology gathering on preventive cardiology; expert-led sessions on prevention-first approaches, risk reduction, lifestyle medicine; 500+ international attendees.